This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
5/13/2022
Ladies and gentlemen, please stand by. Your conference call will begin momentarily. Once again, thank you for your patience and please stand by. Thank you. Thank you. Thank you.
Thank you.
Good morning and welcome to the Better Therapeutics First Quarter 2022 Financial Results and Business Update Conference Call. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you'll need to press star 1 on your telephone. Please be advised that today's conference may be recorded. If you require any further assistance, please press star then 0. I would now like to hand the call over to Kevin Applebaum, co-founder and chief executive officer. Please begin.
You're reading a preview of the BTTX Q1 2022 earnings call.
Free account.
